EMEA Should Adopt More FDA Methods To Speed Drug Approval - CPMP Chair
Executive Summary
The European Medicines Evaluation Agency should consider the adoption of more FDA-style mechanisms to speed approval of important new drugs, Commission for Proprietary Medicinal Products Chairman Jean-Michel Alexandre, PhD, indicated.